Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis

Mesenchymal stromal cells (MSCs) are increasingly used in regenerate medicine. Placenta-derived decidual stromal cells (DSCs) are a novel therapy for acute graft-versus-host-disease (GVHD) and hemorrhagic cystitis (HC) after allogeneic hematopoietic stem cell transplantation (HSCT). DSCs are more im...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Arjang Baygan, Wictor Aronsson-Kurttila, Gianluca Moretti, Babylonia Tibert, Göran Dahllöf, Lena Klingspor, Britt Gustafsson, Bita Khoein, Guido Moll, Charlotta Hausmann, Britt-Marie Svahn, Magnus Westgren, Mats Remberger, Behnam Sadeghi, Olle Ringden
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2017-07-01
coleção:	Frontiers in Immunology
Assuntos:	graft-versus-host disease mesenchymal stromal cells hematopoietic stem cell transplantation hemorrhagic cystitis decidual stromal cells
Acesso em linha:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.00795/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!